Influence of non-nucleoside reverse transcriptase inhibitors (efavirenz and nevirapine) on the pharmacodynamic activity of gliclazide in animal models.

Authors:
Mastan S; Kumar KE.

Journal:
Diabetol Metab Syndr

Publication Year: 2009

DOI:
10.1186/1758-5996-1-15

PMCID:
PMC2765430

PMID:
19825151

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Diabetol Metab Syndr

Abbreviation: Diabetol Metab Syndr

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Endocrinology & Metabolism

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction-ass…
Godoy-Matos AF; Valério CM; Silva Júnior WS and 2 more (2024) - Transparency Score: 3/6
A comparative study of cardiovascular risk stratification methods in type 1 diabetes mellitus patie…
de Araujo FM; Comim FV; Lamounier RN and 5 more (2024) - Transparency Score: 3/6
Anthropometric parameters as a tool for the prediction of metabolic and cardiovascular risk in chil…
Romano A; Masino M; Rivetti S and 4 more (2024) - Transparency Score: 3/6
Clinical inertia in newly diagnosed type 2 diabetes mellitus among patients attending selected heal…
Alvis-Guzman N; Romero M; Salcedo-Mejia F and 9 more (2024) - Transparency Score: 3/6
Clinical outcomes of simultaneous pancreas-kidney transplantation in elderly type II diabetic recip…
Cao Y; Zhao J; Feng G and 5 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests The authors declare that they have no competing interests."

Funding Disclosure
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025